Five young UKE researchers win "Dr. Martini Prize"
Five researchers at UKE accepted Monday (February 13, 2023) the Dr. Martini Awards and EUR 10,000 each for their research into new means of treating childhood kidney disease, findings on cancerous metastases and risk assessment of spinal cord tumours. The awards, which are Germany's oldest for achievements in medicine, were presented by Katharina Fegebank, Senator for Science and Research, and Prof. Dr. Ansgar W. Lohse, Chairman of the Board of Trustees of the Dr. Martini Foundation.
Supporting UKE's young researchers
"We must support our talented young doctors to shape the future of medicine. Thanks to the daily cutting-edge research at UKE, we learn more about diseases and possible therapies that will improve everyone's lives," said Fegebank. Dr. Anne Mühlig and her PhD student Johanna Steingröver, Clinic and Polyclinic for Paediatrics and Adolescent Medicine, won joint first prize for a new drug therapy that can significantly reduce the side effects of severe childhood kidney disease.
Prize for cancer research
Dr. Anastasios Giannou and Dr. Jan Kempski, of the I. Medical Clinic and Polyclinic, shared the joint first prize for proving that the human immune system is a catalyst of colon cancer metastasis. A messenger substance, normally produced to ward off infections, actually spreads cancerous cells in the body. Special therapy could improve follow-up care in future. Dr. Michael Bockmayr, Clinic and Polyclinic for Paediatric Haematology and Oncology, won second prize for improved risk assessment of spinal cord tumours using molecular biological and bioinformatic methods. The tumours are divided into two subtypes with different risks of recurrence, which could lead to more targeted follow-up care.